PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
PT Kalbe Farma Debt to Equity Ratio: 0.0269 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.0269 |
September 30, 2023 | 0.0511 |
June 30, 2023 | 0.09 |
March 31, 2023 | 0.0399 |
December 31, 2022 | 0.0548 |
September 30, 2022 | 0.0527 |
June 30, 2022 | 0.0296 |
March 31, 2022 | 0.0343 |
December 31, 2021 | 0.0286 |
September 30, 2021 | 0.0349 |
June 30, 2021 | 0.0409 |
March 31, 2021 | 0.0394 |
December 31, 2020 | 0.0613 |
September 30, 2020 | 0.0794 |
June 30, 2020 | 0.0985 |
March 31, 2020 | 0.0696 |
December 31, 2019 | 0.0514 |
September 30, 2019 | 0.0478 |
June 30, 2019 | 0.0508 |
March 31, 2019 | 0.0331 |
December 31, 2018 | 0.0244 |
September 30, 2018 | 0.0185 |
June 30, 2018 | 0.026 |
March 31, 2018 | 0.0241 |
December 31, 2017 | 0.0238 |
Date | Value |
---|---|
September 30, 2017 | 0.0383 |
June 30, 2017 | 0.0271 |
March 31, 2017 | 0.0252 |
December 31, 2016 | 0.0235 |
September 30, 2016 | 0.0266 |
June 30, 2016 | 0.0337 |
March 31, 2016 | 0.038 |
December 31, 2015 | 0.0376 |
September 30, 2015 | 0.041 |
June 30, 2015 | 0.045 |
March 31, 2015 | 0.0248 |
December 31, 2014 | 0.0317 |
September 30, 2014 | 0.06 |
June 30, 2014 | 0.0722 |
March 31, 2014 | 0.0655 |
December 31, 2013 | 0.0722 |
September 30, 2013 | 0.0532 |
June 30, 2013 | 0.0585 |
March 31, 2013 | 0.0285 |
December 31, 2012 | 0.029 |
September 30, 2012 | 0.0176 |
June 30, 2012 | 0.0104 |
March 31, 2012 | 0.0192 |
December 31, 2011 | 0.0225 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0269
Minimum
Dec 2023
0.0985
Maximum
Jun 2020
0.0517
Average
0.0508
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Taihe Group Inc | -- |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.732B |
Total Liabilities (Quarterly) | 252.00M |
Shareholders Equity (Quarterly) | 1.371B |
Current Ratio | 4.908 |
Net Debt Paydown Yield | 0.13% |